The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

Ítems similars

• The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
  per: Zipperer, Esther, et al.
  Publicat: (2009)
• Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
  per: Kasprzak, Annika, et al.
  Publicat: (2021)
• Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
  per: Annika Kasprzak, et al.
  Publicat: (2022-04-01)
• Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
  per: Kuendgen, Andrea, et al.
  Publicat: (2011)
• Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment
  per: Germing, Ulrich, et al.
  Publicat: (2013)